Oxford-Harrington Rare Disease Centre is a partnership between the University of Oxford and Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, US with a mission to deliver new treatments for the nearly 500 million people affected by rare diseases worldwide and to advance 40 drugs into clinical trials by 2034.
